Cosmo Pharmaceuticals S.p.A. announced that shareholders elected CEO Mauro Ajani as Chairman, replacing Rolf Stahel, who did not stand for re-election due to statutory age limitation and newly elected Prof. Dr. Maria Grazia Roncarolo, Scientific Director of the San Raffaele Scientific Institute in Milan, Italy, to the board as an Independent Director.